The invention belongs to the field of biological products and the field of
nucleic acid vaccines, and particularly relates to a
virus (oropravirus)-like particle, preparation and application of the
virus (oropravirus)-like particle as a vaccine. The
virus-like particles are Oropers virus-like particles, and the virus-like particles contain proteins encoded by M
genome segments of OROV strains or proteins encoded by
gene segments of the M
genome segments and N proteins of the OROV strains; wherein the corresponding sequence can also be a consistency sequence with the similarity of 75% with the corresponding sequence. Meanwhile, the particle VLP is used as a serum binding
antibody of an
antigen and an evaluation method of a
T cell reaction, and the method can be used for detecting a serum lifting method after vaccine immunization. The invention further provides five
nucleic acid vaccines for coding different functional domains of the OROV and combinations thereof, the
immunogenicity and
T cell reaction induced by the
nucleic acid vaccines under different design strategies are displayed, strong
body fluid and
cell reaction is still kept 154 days after immunization, and it is proved that the
nucleic acid vaccines can induce lasting and efficient
immune reaction, and the
immunogenicity and the
T cell reaction are not influenced. The method can be used as a technical reserve and has huge
clinical significance and application scenarios.